OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, Richard B. Lock, Chelsea Mayoh et al.|Clinical Cancer Research|2019Cited by 53
ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL FUNCTION1Mark D. Pescovitz, Donald Jung, T. Pruett et al.|Transplantation|1998Cited by 46
High dose oral ganciclovir treatment for cytomegalovirus retinitisJacob Lalezari, Charles A. Robinson, Dorothy N. Friedberg et al.|Journal of Clinical Virology|2002Cited by 45
14-Aminocamptothecins: Their Synthesis, Preclinical Activity, and Potential Use for Cancer TreatmentMark Matteucci, Xiaohong Cai, Fanying Meng et al.|Journal of Medicinal Chemistry|2011Cited by 21